Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03916341 · ClinicalTrials.gov registry record · NA
Smoking and Ventricular Repolarization
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT03916341: Completed NA study, sponsored by University of California, Los Angeles.
NCT03916341 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03916341, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization.
Primary Outcome
interval indicative of ventricular repolarization measured on ECG
Interventions
- OTHER control
- OTHER EC with nicotine
- OTHER EC without nicotine
- OTHER TC with nicotine (own brand)
- OTHER research TC with very low level nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2023-04-10 |
| Phase | NA |
What the finished NCT03916341 record still lists
NCT03916341 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 5 interventions - of which control is the first listed.
NCT03916341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03916341 about?
NCT03916341 is a clinical study titled "Smoking and Ventricular Repolarization". Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization.
What is the current status of trial NCT03916341?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2019-10-01. Estimated completion is 2023-04-10.
What interventions are being tested in trial NCT03916341?
The interventions under investigation include: control (OTHER), EC with nicotine (OTHER), EC without nicotine (OTHER), TC with nicotine (own brand) (OTHER), research TC with very low level nicotine (OTHER).
Who is sponsoring clinical trial NCT03916341?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03916341's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI